3v6b
From Proteopedia
(Difference between revisions)
(2 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
==VEGFR-2/VEGF-E complex structure== | ==VEGFR-2/VEGF-E complex structure== | ||
- | <StructureSection load='3v6b' size='340' side='right' caption='[[3v6b]], [[Resolution|resolution]] 3.21Å' scene=''> | + | <StructureSection load='3v6b' size='340' side='right'caption='[[3v6b]], [[Resolution|resolution]] 3.21Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[3v6b]] is a 2 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[3v6b]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Orf_virus Orf virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3V6B OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3V6B FirstGlance]. <br> |
- | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.205Å</td></tr> |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3v6b FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3v6b OCA], [https://pdbe.org/3v6b PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3v6b RCSB], [https://www.ebi.ac.uk/pdbsum/3v6b PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3v6b ProSAT]</span></td></tr> | |
- | + | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
- | == Disease == | ||
- | [[http://www.uniprot.org/uniprot/VGFR2_HUMAN VGFR2_HUMAN]] Defects in KDR are associated with susceptibility to hemangioma capillary infantile (HCI) [MIM:[http://omim.org/entry/602089 602089]]. HCI are benign, highly proliferative lesions involving aberrant localized growth of capillary endothelium. They are the most common tumor of infancy, occurring in up to 10% of all births. Hemangiomas tend to appear shortly after birth and show rapid neonatal growth for up to 12 months characterized by endothelial hypercellularity and increased numbers of mast cells. This phase is followed by slow involution at a rate of about 10% per year and replacement by fibrofatty stroma.<ref>PMID:11807987</ref> <ref>PMID:18931684</ref> Note=Plays a major role in tumor angiogenesis. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/VEGFH_ORFN2 VEGFH_ORFN2] Induces endothelial proliferation. |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 22: | Line 18: | ||
</div> | </div> | ||
<div class="pdbe-citations 3v6b" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 3v6b" style="background-color:#fffaf0;"></div> | ||
+ | |||
+ | ==See Also== | ||
+ | *[[VEGF 3D Structures|VEGF 3D Structures]] | ||
+ | *[[3D structures of vascular endothelial growth factor receptor|3D structures of vascular endothelial growth factor receptor]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
[[Category: Orf virus]] | [[Category: Orf virus]] | ||
- | [[Category: | + | [[Category: Ballmer-Hofer K]] |
- | [[Category: | + | [[Category: Brozzo MS]] |
- | [[Category: | + | [[Category: Kisko K]] |
+ | [[Category: Leppanen V-M]] | ||
+ | [[Category: Winkler FK]] |
Current revision
VEGFR-2/VEGF-E complex structure
|